Giri Chenji

Head- Program Management, Manufacturing and Technology, Immuneel Therapeutics

I enjoy technical and scientific work and am currently integrating and industrializing Immuneel's discovery research, development, and manufacturing operations. Responsibility for CMC Project Management, and work closely with the operating team to plan and execute our strategy in service of Immuneel's mission to bring affordable and accessible cell therapies to India.

Life Sciences operations expert with 20+ years experience, and a passion for commercializing biologics in a start-up type environment. Global operational and consulting experience across the bio/pharma value chain (US, Europe, India) - program management, product development, business process design/improvement, organization design, stakeholder management, supply chain, manufacturing and quality, process validation, facility start-up/commissioning. Breadth and depth of exposure across biotech, pharmaceutical and chemical industries. Skilled at building business relationships and decision-making. Recognized for business acumen, leading teams and delivering results in matrix and functional organizations, with demonstrated experience in influencing without direct authority. Strong presenter with a sense of audience and executive presence. Accomplished written and verbal communication skills. Expertise in designing, implementing and improving internal systems and processes.

16:30 - 17:00 hrs.

Friday 13th october

The Future of Healthcare Through Innovations

  • Role of Genomics in Biotech
  • Personalized Health
  • Prevention as an Approach to Wellbeing
  • Patient-centric Healthcare


Giridhar K. Chenji, Head- Program Management, Manufacturing and Technology, Immuneel Therapeutics

Kumar Sankaran, CEO, Luciene Rich Bio Ltd

Session Moderated by:

Manbeena Chawla PH.D, Executive Editor, Biospectrum Magazine India